Gateway Wealth Partners LLC Reduces Position in Cigna Group $CI

Gateway Wealth Partners LLC decreased its position in shares of Cigna Group (NYSE:CIFree Report) by 57.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,383 shares of the health services provider’s stock after selling 1,887 shares during the period. Gateway Wealth Partners LLC’s holdings in Cigna Group were worth $381,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Evercore Wealth Management LLC boosted its holdings in shares of Cigna Group by 2.8% in the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock valued at $347,000 after acquiring an additional 35 shares during the period. Cary Street Partners Investment Advisory LLC increased its holdings in shares of Cigna Group by 11.0% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after acquiring an additional 36 shares during the period. OLD National Bancorp IN increased its holdings in shares of Cigna Group by 3.7% in the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after acquiring an additional 37 shares during the period. IHT Wealth Management LLC raised its position in Cigna Group by 2.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock valued at $423,000 after purchasing an additional 38 shares during the last quarter. Finally, Whetstone Capital Advisors LLC raised its position in Cigna Group by 4.9% in the 4th quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock valued at $228,000 after purchasing an additional 39 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of NYSE CI opened at $282.24 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The stock has a fifty day moving average price of $286.02 and a 200 day moving average price of $281.28. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The company has a market cap of $74.58 billion, a PE ratio of 11.68, a P/E/G ratio of 0.96 and a beta of 0.29.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts forecast that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 25.82%.

Analysts Set New Price Targets

CI has been the topic of several research reports. The Goldman Sachs Group raised their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Barclays upped their target price on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Raymond James Financial downgraded shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and decreased their target price for the stock from $350.00 to $320.00 in a research note on Monday, August 3rd. Mizuho raised their price target on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Finally, Wells Fargo & Company boosted their price target on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and a consensus price target of $339.45.

View Our Latest Stock Analysis on CI

Insider Transactions at Cigna Group

In other news, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.60% of the company’s stock.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.